Exercise Plus Behavioral Management in Patients with Alzheimer's Disease
JAMA 290:2015-2022, Teri,L.,et al, 2003
Efficacy and Tolerability of Donepezil in Vascular Dementia
Stroke 34:2323-2332, Black,S.,et al, 2003
Identification of New Presenilin Gene Mutations in Early-Onset Familial Alzheimer Disease
Arch Neurol 60:1541-1544,1521, Tedde,A.,et al, 2003
Loss of Calculation Abilities in Patients with Mild and Moderate Alzheimer Disease
Arch Neurol 60:1585-1589, Martin,R.C.,et al, 2003
The Topography of Metabolic Deficits in Posterior Cortical Atrophy (the Visual Variant of Alzheimers Disease) with FDG-PET
JNNP 74:1521-1529, Nestor,P.J.,et al, 2003
Silent Infarcts Demonstrated by Diffusion-Weighted MRI in CADASIL
Eur Neurol 49: 178-180, Moon,S.Y.,et al, 2003
Diagnosis and Complications of Cushings Syndrome: A Consensus Statement
J Clin Endocrinol Metab 88:5593-5602, Arnaldi,G.,et al, 2003
Generalized Convulsive Status Epilepticus in Creutzfeldt-Jakob Disease
Seizure 12:403-406, Neufeld,M.Y.,et al, 2003
A Practical Approach to the Diagnosis and Management of MELAS: Case Report and Review
The Neurologist 8:302-312, Thambisetty,M.,et al, 2002
Subacute Sclerosing Panencephalitis
Postgrad Med J 78:63-70, Garg, R.K.,et al, 2002
Drug-Induced Pisa Syndrome (Pleurothotomus)
CNS Drugs 10:166-174, Suzuki, T. & Matsuzaka, H., 2002
Abnormal Diffusion-Weighted Magnetic Resonance Imaging in Creutzfeldt-Jakob Disease Following Corneal Transplantations
Arch Neurol 59:637-639, Rabinstein,A.A.,et al, 2002
Efficacy of Galantamine in Probable Vascular Dementia and Alzheimer's Disease Combined with Cerebrovascular Disease: A Randomised Trial
Lancet 359:1283-1290,1265, Erkinjuntti,T.,et al, 2002
Alzheimer Disease
JAMA 287:2335-2338, Cummings,J.L. &Cole,G., 2002
Emerging Patterns of Diffusion-Weighted MR Imaging in Creutzfeldt-Jakob Disease: Case Report and Review of the Literature
AJNR 23:550-556, Mao-Draayer,Y.,et al, 2002
Hormone Replacement Therapy and Incidence of Alzheimer Disease in Older Women
JAMA 288:2123-2129,2170, Zandi,P.P.,et al, 2002
Effect of Radiotherapy and Other Treatment-Related Factors on Mid-Term to Long-Term Cognitive Sequelae in Low-Grade Gliomas: A Comparative Study
Lancet 360:1361-1368, Klein,M.,et al, 2002
Abnormality of Gait as a Predictor of Non-Alzheimer's Dementia
NEJM 347:1761-1768, Verghese,J.,et al, 2002
Incidence and Outcome of Mild Cognitive Impairment in a Population-Based Prospective Cohort
Neurol 59;1594-1599, Larrieu,S.,et al, 2002
Fragile X Premutation Carriers: Characteristic MR Imaging Findings of Adult Male Patients with Progressive Cerebellar and Cognitive Dysfunction.
AJNR 23:1757-1766, Brunberg,J.A.,et al, 2002
Thalamic Venous Infarction as a Cause of Subacute Dementia
Neurol 58:1689-1691, Krolak-Salmon,P.,et al, 2002
Conspicuity and Evolution of Lesions in Creutzfeldt-Jakob Disease at Diffusion-Weighted Imaging
AJNR 23:1164-1172,1070, Murata,T.,et al, 2002
Natural History of Mild Cognitive Impairment in Older Persons
Neurol 59:198-205, Bennett,D.A.,et al, 2002
Sporadic Creutzfeldt-Jakob Disease and Surgery
Neurol 59:543-548, Ward,H.J.T.,et al, 2002
Clinicopath Conf, Neuronal Ceroid Lipofuscinosis, Late-Onset Infantile Subtype
NEJM 347:672-680, Case 27-2002, 2002
Familial Dementia With Lewy Bodies
Arch Neurol 59:1622-1630, Tsuang,D.W.,et al, 2002
Potentially Reversible Conditions in 1000 Consecutive Memory Clinic Patients
JNNP 73:390-394, Hejl,A.,et al, 2002
Reduced Incidence of AD with NSAID But Not H2 Receptor Antagonists
Neurol 59:880-886, Zandi,P.P.,et al, 2002
Prevalence of Neuropsychiatric Symptoms in Dementia and Mild Cognitive Impairment
JAMA 288:1475-1483, Lyketsos,C.G.,et al, 2002
Plasma Homocysteine as a Risk Factor for Dementia and Alzheimer's Disease
NEJM 346:476-483, 466, Seshadri,S.,et al, 2002
Alcohol Consumption and Risk of Dementia: the Rotterdam Study
Lancet 359:281-286, Ruitenberg,A.,et al, 2002
Epilepsy Presenting as AD: Neuroimaging, Electroclinical Features, and Response to Treatment
Neurol 58:298-301, Hogh,P.,et al, 2002
Tau Protein and 14-3-3 Protein in the Differential Diagnosis of Creutzfeldt-Jakob Disease
Neurol 58:192-197, Otto,M.,et al, 2002
Recombinant Interferon-a-induced Chorea and Frontal Subcortical Dementia
Neurol 58:328-330, Moulignier,A.,et al, 2002
Correlation of Diffusion-Weighted Magnetic Resonance Imaging With Neuropathology in Creutzfeldt-Jakob Disease
Arch Neurol 59:128-134, Mittal,S.,et al, 2002
Research Evaluation and Prospective Diagnosis of Dementia With Lewy Bodies
Arch Neurol 59:43-46,29, Lopez,O.L,et al, 2002
Sporadic CJD Clinically Mimicking Variant CJD With Bilateral Increased Signal in the Pulvinar
Neurol 58:148-149, Haik,S.,et al, 2002
Homocysteine, Silent Brain Infarcts, and White Matter Lesions: The Rotterdam Scan Study
Ann Neurol 51:285-289,279, Vermeer,S.E.,et al, 2002
Functional Deficits in Patients with Mild Cognitive Impairment
Neurol 58:758-764, Tabert,M.H.,et al, 2002
The Neurological Masquerade of Intravascular Lymphomatosis
Arch Neurol 59:439-443, Beristain,X.&Azzarelli,B., 2002
Adverse Long-term Effects of Brain Radiotherapy in Adult Low-grade Glioma Patients
Neurol 56:1285-1290,1255, Surma-aho,O.,et al, 2001
CSF Detection of the 14-3-3 Protein in Unselected Patients with Dementia
Neurol 56:1528-1533, Burkhard,P.R.,et al, 2001
Stem-Cell Research: Drawing the Line
Lancet 358:163,217, Greenberg,D.S., 2001
Return to Driving After Head Injury
JNNP 70:761-766, Hawley,C.A., 2001
Drugs for Alzheimer's Disease
BMJ 323:123-124, O'Brien,J.T . &Ballard,C.G., 2001
Fits and Strokes
Lancet 358:120, Sharma,P.,et al, 2001
Galantamine (Reminyl) for Alzheimer's Disease
Medical Letter 43:53-54, , 2001
Use of 14-3-3 and Other Brain-specific Proteins in CSF in the Diagnosis of Variant Creutzfeldt-Jakob Disease
JNNP 70:744-748, Green,A.J.E.,et al, 2001
Anosmia in Dementia is Associated with Lewy Bodies Rather Than Alzheimer's Pathology
JNNP 70:739-743,720, McShane,R.H.,et al, 2001
High-Dose Estradiol Improves Cognition for Women with AD, Results of a Randomized Study
Neurol 57:605-612, Asthana,S.,et al, 2001